Brendan D. Manning
Harvard University(US)MRC Clinical Trials Unit at UCL(GB)Bioanalytica (Switzerland)(CH)University College London(GB)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, RNA modifications and cancer, Tuberous Sclerosis Complex Research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → AKT/PKB Signaling: Navigating Downstream(2007)6,033 cited
- → AKT/PKB Signaling: Navigating the Network(2017)3,588 cited
- → The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism(2019)2,066 cited
- → Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1(2010)1,954 cited
- → Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway(2002)1,548 cited
- → Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex(2004)1,364 cited